Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 30,000 shares at $133.29 ($4.0M) on 2022-07-11, disclosed to the SEC on 2022-07-11.
Open-market sale of $4.0M KRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.29 | 15,000 | $2.0M | 50.0% |
| 2 | $133.29 | 15,000 | $2.0M | 50.0% |
| Total | $133.29 avg | 30,000 | $4.0M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |